{"gene":"SPINK5","run_date":"2026-06-10T07:46:40","timeline":{"discoveries":[{"year":2007,"finding":"LEKTI is produced as a precursor that is rapidly cleaved by furin at multiple sites, generating a variety of single or multidomain secreted fragments (D1, D5, D6, D8-D11, D9-D15) in keratinocytes and epidermis. All fragments except D1 specifically inhibit KLK5, KLK7, and KLK14. The D8-D11 fragment shows the strongest inhibition of KLK5 via a rapid, tight (near-irreversible) interaction. This KLK5-LEKTI interaction is pH-dependent: at acidic pH, active KLK5 is released from the complex, providing a mechanism by which the epidermal pH gradient regulates KLK5 activity and corneodesmosomal cleavage in the stratum corneum.","method":"Furin inhibitor treatment in cultured keratinocytes, biochemical antibody panel mapping of secreted fragments, kinetic analysis of inhibition (Ki, kass, kdis), pH-dependent binding/release assays","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinetic reconstitution with multiple LEKTI fragments and target proteases, corroborated by furin inhibitor experiments and pH-dependent release assays in a single rigorous study","pmids":["17596512"],"is_preprint":false},{"year":2003,"finding":"LEKTI is expressed as a 145 kDa full-length protein and a 125 kDa isoform in differentiated human primary keratinocytes; both are N-glycosylated and processed post-ER into C-terminal fragments of 42, 65, and 68 kDa that are secreted. Processing is blocked by a furin inhibitor, and in vitro cleavage of the recombinant 145 kDa precursor by furin generates the 65 and 68 kDa C-terminal fragments, establishing furin as the processing protease.","method":"Western blot with monoclonal/polyclonal antibodies, furin inhibitor treatment, in vitro furin cleavage of recombinant LEKTI precursor, N-glycosylation analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution (in vitro furin cleavage) combined with cellular pharmacological inhibition and multiple orthogonal detection methods, replicated across multiple fragment types","pmids":["12915442"],"is_preprint":false},{"year":2005,"finding":"In normal human epidermis, LEKTI is localized within lamellar granules (LGs) but is spatially separated from KLK7 and KLK5 within that compartment. LEKTI is expressed and secreted into extracellular spaces of the superficial stratum granulosum earlier than KLK7 and KLK5, suggesting the LG system uses differential timing of secretion to prevent premature degradation of stratum corneum by sequestering the inhibitor from its targets until the appropriate epidermal layer is reached.","method":"Confocal laser scanning microscopy and immunoelectron microscopy with co-localization analysis in normal vs. Netherton syndrome skin","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct subcellular localization by immunoelectron microscopy with functional inference from NS patient comparison; two orthogonal imaging methods in one study","pmids":["15675955"],"is_preprint":false},{"year":2005,"finding":"Recombinant LEKTI fragments containing domains 6-8 and 9-12 are potent inhibitors of kallikrein KLK5 (a trypsin-like protease) with Ki of 1.2–5.5 nM at pH 8.0 and 10–20 nM at pH 5.0; dissociation half-life is 20–25 min indicating tight, specific binding. Only fragment 6-9' (not 9-12) inhibits KLK7 (a chymotrypsin-like protease) with Ki of 11 nM at pH 8.0 in a rapidly reversible manner, establishing differential domain selectivity for KLK5 vs KLK7.","method":"In vitro enzyme inhibition kinetics with recombinant LEKTI fragments and recombinant KLK5/KLK7; measurement of Ki, kass, kdis at pH 8.0 and pH 5.0","journal":"Biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — rigorous in vitro kinetic reconstitution with recombinant proteins, multiple pH conditions, and differential fragment comparisons","pmids":["16307483"],"is_preprint":false},{"year":2006,"finding":"In Netherton syndrome patient skin, the magnitude of serine protease activation correlates with barrier defect severity and inversely with residual LEKTI expression. LEKTI co-localizes with KLK5 and KLK7 in the stratum corneum and inhibits both. Excess serine protease activity causes loss of corneodesmosomes via KLK-mediated degradation of desmoglein 1 (DSG1) and desmocollin 1 (DSC1), while compensatory upregulation of DSG3/DSC3 maintains nucleated epidermal integrity.","method":"Serine protease activity assays, LEKTI immunostaining, in situ zymography, western blot for desmosomal proteins in NS patient biopsies stratified by phenotype severity","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal assays in human patient tissue; single study but with defined phenotypic stratification and mechanistic readouts","pmids":["16601670"],"is_preprint":false},{"year":2011,"finding":"LEKTI is synthesized from three distinct high-molecular-weight precursors that undergo a defined proteolytic cascade in the epidermis. Antibody mapping, N-terminal sequencing, and site-specific mutagenesis defined the amino acid sequences of the physiologically generated LEKTI polypeptides and three novel processing intermediates. The most effective fragments against desquamation-related kallikreins (KLK5, KLK7) were identified; LEKTI polypeptides inhibit KLK-mediated proteolysis of desmoglein-1, and quantification shows ratios of LEKTI polypeptides to active KLK5 in the uppermost epidermis are compatible with fine-tuned inhibition.","method":"Antibody mapping, N-terminal sequencing, site-specific mutagenesis, in vitro inhibition assays, quantitative western blot of epidermal extracts","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — N-terminal sequencing plus mutagenesis plus functional inhibition assays in a single study; multiple orthogonal methods establishing the proteolytic cascade","pmids":["21697885"],"is_preprint":false},{"year":2012,"finding":"The common SPINK5 variant E420K (Glu420Lys) increases the likelihood of furin-dependent cleavage of the LEKTI precursor within the D6-D7 linker region, reversing the cleavage priority for LEKTI activation and preventing formation of the D6D9 fragment, which has the strongest inhibitory activity against KLK5-mediated desmoglein-1 (DSG1) degradation. In 420KK epidermis, KLK5, KLK7, and elastase-2 activities are enhanced, DSG1 expression is reduced, and profilaggrin proteolysis is accelerated. Additionally, 420KK epidermis shows increased expression of the proallergic cytokine TSLP.","method":"In vitro furin cleavage assays, in situ and gel zymographies for protease activity, immunohistochemistry, western blot for DSG1 and profilaggrin, TSLP immunostaining in patient epidermis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biochemical reconstitution of altered furin cleavage combined with functional protease activity assays and downstream substrate analysis, multiple orthogonal methods in one study","pmids":["22730493"],"is_preprint":false},{"year":2004,"finding":"Recombinant LEKTI domains 6-9' inhibit trypsin (Ki = 356 nM) and subtilisin A (Ki = 193 nM) by a noncompetitive mechanism, whereas recombinant LEKTI domain 6 alone does not inhibit subtilisin A but competitively inhibits trypsin (Ki = 200 nM). Full-length LEKTI inhibits plasmin, cathepsin G, and elastase but domains 6-9' do not, demonstrating domain-specific inhibitory activity.","method":"Baculovirus expression and purification of recombinant LEKTI fragments; enzyme inhibition kinetics determining Ki and inhibition mechanism","journal":"Protein expression and purification","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified recombinant protein and defined kinetic assays; single lab but rigorous mechanistic characterization","pmids":["15039071"],"is_preprint":false},{"year":2006,"finding":"SPINK5 generates three classes of alternatively spliced transcripts encoding three LEKTI isoforms: a 15-domain isoform, a 13-domain isoform, and a longer isoform with a 30-amino acid insertion between domains 13 and 14. In differentiated human keratinocytes, all three LEKTI isoforms are translated into protein, and each precursor generates distinct secreted C-terminal proteolytic fragments from similar cleavage sites, providing an additional mechanism for diversifying bioactive LEKTI fragments.","method":"RT-PCR characterization of alternative transcripts, western blot detection of isoform proteins in differentiated keratinocytes, identification of secreted C-terminal fragments","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — alternative splicing verified by RT-PCR and protein confirmed by western blot; functional implication inferred from secreted fragment analysis","pmids":["16374478"],"is_preprint":false},{"year":2002,"finding":"LEKTI is a 15-domain Kazal-type serine proteinase inhibitor isolated from human blood filtrate. Two of the 15 domains closely match the classical Kazal-type pattern (with 6 Cys), while 13 domains have only 4 Cys. Three recombinant LEKTI domains were shown to have significant trypsin-inhibiting activity.","method":"Protein isolation from blood filtrate, cDNA cloning, domain structure analysis, in vitro trypsin inhibition assay with recombinant domains","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro inhibition assay with recombinant domains; initial characterization in a single study, foundational but limited in scope","pmids":["11943586"],"is_preprint":false},{"year":2010,"finding":"Lentiviral gene transfer of SPINK5 into Netherton syndrome keratinocytes restores LEKTI expression and corrects epidermal architecture in organotypic cultures and in vivo mouse/human skin grafts. Even partial restoration of LEKTI expression in limited cell numbers confers a broader bystander benefit, consistent with LEKTI acting as a secreted inhibitor that can diffuse to neighboring cells.","method":"HIV-1-based lentiviral vector transduction of NS keratinocytes, organotypic culture, mouse/human skin engraftment model, immunofluorescence for LEKTI expression and epidermal architecture","journal":"Molecular therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo reconstitution models with functional correction readout; single lab study using two model systems","pmids":["20877344"],"is_preprint":false},{"year":2010,"finding":"AAV2-mediated gene transfer of full-length SPINK5 cDNA into LEKTI-deficient NS keratinocytes produces a five-fold increase in SPINK5 mRNA reaching ~75% of normal, and restored LEKTI protein demonstrates serine protease inhibitory activity in a hydrolytic activity assay at levels approaching those of healthy keratinocytes.","method":"rAAV2 transduction, RT-PCR for mRNA quantification, hydrolytic activity assay for LEKTI function in transduced vs. normal keratinocytes","journal":"Journal of dermatological science","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — functional rescue assay in patient-derived cells; single lab, single method for activity measurement","pmids":["21251800"],"is_preprint":false},{"year":2007,"finding":"Genotype-phenotype correlations in Japanese NS patients show that LEKTI truncation length correlates with cutaneous severity, growth retardation, and skin infection. Using recombinant LEKTI proteins of varying domain length, trypsin-like (Phe-Ser-Arg-) protease activity in stratum corneum is predominantly inhibited by LEKTI domains 6-12, plasmin- and trypsin-like (Pro-Phe-Arg-) activities by domains 12-15, and chymotrypsin-like activity by all domains; furin-like activity is not inhibited by any domain. KLK5 and KLK7 levels are significantly elevated in NS patient stratum corneum and serum.","method":"Recombinant LEKTI domain expression and stratum corneum protease activity assays with fluorogenic substrates; KLK ELISA in patient samples; clinical correlation analysis","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro inhibition assays with recombinant domain fragments correlated with patient phenotypes; single lab with multiple domain comparisons","pmids":["17989726"],"is_preprint":false},{"year":2016,"finding":"In atopic dermatitis lesional skin, KLK7 secretion from lamellar granules is impaired, and LEKTI expression is upregulated compared to normal skin. KLK activity measured by in situ zymography on tape-stripped corneocytes is not significantly elevated in AD lesions despite increased KLK7 protein, indicating that elevated LEKTI expression constitutes a compensatory mechanism preventing further barrier dysfunction by suppressing KLK activity.","method":"Western blot for corneodesmosin degradation patterns, in situ zymography on tape-stripped corneocytes, electron microscopy and immunostaining for KLK7 secretion from lamellar granules, LEKTI immunostaining","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods in patient tissue; single lab study with both protein and activity-level readouts","pmids":["27769847"],"is_preprint":false},{"year":2019,"finding":"SPINK5 overexpression in esophageal cancer cells inhibits the Wnt/β-catenin signaling pathway: SPINK5 inhibits GSK3β phosphorylation and promotes β-catenin protein degradation (confirmed with LiCl or MG-132 co-treatment), reducing cell proliferation, migration, and invasion. Co-immunoprecipitation suggested an indirect interaction between SPINK5 and components of this pathway. In vivo, SPINK5 overexpression significantly inhibits esophageal cancer cell growth in a xenograft model.","method":"Western blot for Wnt/β-catenin pathway components, LiCl/MG-132 pharmacological rescue experiments, in vivo xenograft model, bioinformatics pathway analysis","journal":"Cancer medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — overexpression assay with pathway western blot; indirect interaction not directly demonstrated; single lab, no mutagenesis to map the mechanism","pmids":["30868765"],"is_preprint":false},{"year":2022,"finding":"miR-5100 directly targets SPINK5 (confirmed by luciferase reporter assay), reducing SPINK5 expression and thereby activating STAT3 phosphorylation in melanoma cells. Reduced SPINK5 promotes epithelial-mesenchymal transition and melanoma metastasis. Co-immunoprecipitation confirmed an indirect interaction between SPINK5 and STAT3. Metformin suppresses the miR-5100/SPINK5/STAT3 axis, reducing melanoma cell metastasis to lung in a mouse model.","method":"Luciferase reporter assay for miR-5100 targeting SPINK5, western blot for STAT3 phosphorylation, migration/wound healing assays, co-immunoprecipitation for SPINK5-STAT3 interaction, in vivo mouse lung metastasis model","journal":"Cellular & molecular biology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter validates direct miRNA targeting; Co-IP and in vivo rescue provide mechanistic pathway placement; single lab study","pmids":["35705923"],"is_preprint":false},{"year":2019,"finding":"Compound K (an active ginsenoside metabolite) increases SPINK5 gene promoter activity and SPINK5/LEKTI protein expression in UVB-irradiated HaCaT keratinocytes, resulting in decreased downstream KLK5, KLK7, and PAR2 expression. In UVB-irradiated mouse and DNCB-induced atopic dermatitis mouse models, CK treatment restores SPINK5 expression and normalizes the expression of desquamation-related proteins.","method":"Transactivation (promoter activity) assay, RT-PCR, western blot, mouse models with TEWL and histology readouts","journal":"Journal of ginseng research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pharmacological upregulation of SPINK5 with downstream protease readouts; single lab, no direct mechanistic dissection of SPINK5 function itself","pmids":["33192123"],"is_preprint":false}],"current_model":"SPINK5 encodes LEKTI, a secreted multi-domain Kazal-type serine protease inhibitor that is synthesized as a high-molecular-weight precursor (from three alternative splice isoforms), processed intracellularly by furin at multiple sites into bioactive fragments, and secreted from lamellar granules into the extracellular spaces of the stratum granulosum, where its fragments differentially and potently inhibit epidermal kallikreins KLK5, KLK7, and KLK14 in a pH-dependent manner to regulate desquamation, corneodesmosome integrity, and skin barrier homeostasis; loss-of-function mutations in SPINK5 cause Netherton syndrome through unchecked kallikrein activity and proteolysis of desmoglein-1 and other structural proteins, while a common E420K variant alters furin cleavage priorities to reduce the most potent inhibitory fragment and predispose to atopic dermatitis."},"narrative":{"mechanistic_narrative":"SPINK5 encodes LEKTI, a multi-domain Kazal-type serine protease inhibitor that governs epidermal desquamation and skin barrier homeostasis by restraining kallikrein-mediated proteolysis [PMID:17596512, PMID:11943586]. LEKTI is synthesized as high-molecular-weight precursors from three alternatively spliced transcripts (15-domain, 13-domain, and a 30-amino-acid-insertion isoform) and is rapidly cleaved by furin at multiple sites into single- and multi-domain secreted fragments [PMID:12915442, PMID:16374478]. These fragments display domain-selective, pH-dependent inhibition of the epidermal kallikreins KLK5, KLK7, and KLK14: multidomain fragments such as D8-D11 and domains 6-12 bind the trypsin-like KLK5 with near-irreversible, nanomolar affinity that is released under the acidic pH of the stratum corneum, while only the domain 6-9' fragment inhibits the chymotrypsin-like KLK7, providing a pH- and layer-dependent switch for protease activity [PMID:17596512, PMID:16307483, PMID:17989726]. Spatially, LEKTI is stored in lamellar granules and secreted into the stratum granulosum ahead of and physically separated from its target kallikreins, ensuring inhibition is engaged only at the appropriate epidermal layer [PMID:15675955]. By limiting kallikrein activity, LEKTI protects corneodesmosomal proteins desmoglein-1 and desmocollin-1 from degradation; loss-of-function SPINK5 mutations cause Netherton syndrome, in which unchecked serine protease activity degrades these structural proteins and the magnitude of activation scales with barrier-defect severity [PMID:16601670, PMID:22730493]. Reintroduction of SPINK5 into patient keratinocytes restores LEKTI expression, protease inhibition, and epidermal architecture, confirming the gene's causal role [PMID:20877344, PMID:21251800]. A common E420K variant redirects furin cleavage to prevent formation of the most potent anti-KLK5 fragment, enhancing kallikrein and elastase activity, accelerating desmoglein-1 and profilaggrin proteolysis, and inducing the proallergic cytokine TSLP [PMID:22730493]. Beyond the epidermis, SPINK5 has been reported to act as a tumor suppressor that restrains Wnt/β-catenin signaling in esophageal cancer and STAT3 signaling in melanoma [PMID:30868765, PMID:35705923].","teleology":[{"year":2002,"claim":"Established LEKTI as a 15-domain Kazal-type serine protease inhibitor with intrinsic protease-inhibitory activity, defining the molecular class of the protein.","evidence":"Protein isolation from blood filtrate, cDNA cloning, and in vitro trypsin inhibition with recombinant domains","pmids":["11943586"],"confidence":"Medium","gaps":["Physiological target proteases not identified","No connection to epidermal biology yet established","Most of the 15 domains untested for activity"]},{"year":2003,"claim":"Identified furin as the processing protease that converts the LEKTI precursor into secreted C-terminal fragments, defining how the inhibitor is matured.","evidence":"Western blot of keratinocyte isoforms, furin inhibitor treatment, and in vitro furin cleavage of recombinant precursor","pmids":["12915442"],"confidence":"High","gaps":["Functional differences among fragments not resolved","Target proteases of each fragment not yet defined"]},{"year":2004,"claim":"Demonstrated domain-specific and mechanistically distinct inhibition, showing different LEKTI fragments inhibit different proteases by competitive vs noncompetitive modes.","evidence":"Baculovirus-expressed recombinant fragments with kinetic Ki and inhibition-mechanism assays against trypsin, subtilisin, plasmin, cathepsin G, elastase","pmids":["15039071"],"confidence":"High","gaps":["Tested proteases are not the principal epidermal kallikreins","Physiological relevance of each target not established"]},{"year":2005,"claim":"Defined the differential domain selectivity for the desquamation kallikreins KLK5 vs KLK7 and the pH-dependence of binding, linking LEKTI to epidermal protease regulation.","evidence":"In vitro inhibition kinetics with recombinant LEKTI fragments and KLK5/KLK7 at pH 5.0 and 8.0, plus subcellular localization by confocal and immunoelectron microscopy","pmids":["16307483","15675955"],"confidence":"High","gaps":["KLK14 not yet included","In vivo timing of secretion inferred, not directly measured","Substrate consequences of unchecked kallikreins not yet shown"]},{"year":2006,"claim":"Connected LEKTI loss to corneodesmosome destruction in Netherton syndrome, identifying DSG1/DSC1 as the kallikrein substrates whose degradation drives the barrier defect.","evidence":"Serine protease activity assays, in situ zymography, and desmosomal protein western blots in phenotype-stratified NS patient biopsies","pmids":["16601670"],"confidence":"Medium","gaps":["Causality from patient correlation only","Compensatory DSG3/DSC3 mechanism not mechanistically dissected"]},{"year":2006,"claim":"Showed alternative splicing yields three LEKTI isoforms each generating distinct secreted fragments, expanding the diversity of bioactive inhibitors.","evidence":"RT-PCR transcript characterization and western blot of isoform proteins and secreted fragments in differentiated keratinocytes","pmids":["16374478"],"confidence":"Medium","gaps":["Functional differences between isoform-derived fragments not quantified","Tissue-specific isoform regulation unknown"]},{"year":2007,"claim":"Resolved the mechanism by which the epidermal pH gradient regulates kallikrein activity, showing acidic pH releases active KLK5 from the most potent D8-D11 fragment.","evidence":"Furin inhibitor treatment, antibody fragment mapping, and pH-dependent binding/release kinetics in keratinocytes","pmids":["17596512"],"confidence":"High","gaps":["KLK14 regulation less characterized","In vivo pH-dependent release in stratum corneum inferred from in vitro kinetics"]},{"year":2007,"claim":"Mapped genotype-phenotype correlations and domain-resolved protease specificity, linking LEKTI truncation length to clinical severity.","evidence":"Recombinant domain fragments tested against stratum corneum protease activities, KLK ELISA in patient samples, and clinical correlation in Japanese NS patients","pmids":["17989726"],"confidence":"Medium","gaps":["Correlative, not causal, link between domain length and phenotype","Single population cohort"]},{"year":2010,"claim":"Provided causal proof that restoring SPINK5/LEKTI corrects the Netherton phenotype, validating the gene as the disease driver and therapeutic target.","evidence":"Lentiviral and AAV2 gene transfer into NS keratinocytes with organotypic culture, skin grafting, and hydrolytic protease-inhibition assays","pmids":["20877344","21251800"],"confidence":"Medium","gaps":["Single-lab model systems","Durability and safety of correction in vivo not addressed"]},{"year":2011,"claim":"Defined the precise proteolytic cascade and quantified LEKTI-to-KLK5 ratios in vivo, establishing that fragment generation supports fine-tuned inhibition.","evidence":"Antibody mapping, N-terminal sequencing, site-specific mutagenesis, and quantitative western blot of epidermal extracts","pmids":["21697885"],"confidence":"High","gaps":["Regulation of cascade ordering not fully resolved","In vivo spatial dynamics of intermediates not visualized"]},{"year":2012,"claim":"Mechanistically explained the atopic-dermatitis-associated E420K variant, showing it reroutes furin cleavage to abolish the most potent anti-KLK5 fragment and amplify proteolysis and TSLP induction.","evidence":"In vitro furin cleavage assays, in situ and gel zymography, DSG1/profilaggrin western blots, and TSLP immunostaining in 420KK epidermis","pmids":["22730493"],"confidence":"High","gaps":["Population-level penetrance of variant not addressed","Link from TSLP induction to clinical atopy not directly tested"]},{"year":2016,"claim":"Showed LEKTI upregulation acts as a compensatory brake in atopic dermatitis, where impaired KLK7 secretion and elevated LEKTI keep net protease activity in check.","evidence":"In situ zymography on tape-stripped corneocytes, electron microscopy of lamellar granule secretion, and LEKTI immunostaining in AD lesional skin","pmids":["27769847"],"confidence":"Medium","gaps":["Trigger for compensatory LEKTI upregulation unknown","Single-lab patient cohort"]},{"year":2022,"claim":"Extended SPINK5 function beyond the epidermis, placing it as a target of miR-5100 that restrains STAT3 signaling and melanoma metastasis.","evidence":"Luciferase reporter for miR-5100 targeting, STAT3 phosphorylation western blots, Co-IP, and in vivo lung metastasis model with metformin","pmids":["35705923"],"confidence":"Medium","gaps":["SPINK5-STAT3 interaction described as indirect, not mapped","Mechanism linking a secreted protease inhibitor to intracellular STAT3 unresolved"]},{"year":null,"claim":"How a secreted Kazal-type protease inhibitor mechanistically engages intracellular signaling cascades (Wnt/β-catenin, STAT3) to act as a tumor suppressor remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No direct molecular link between LEKTI and intracellular signaling components","Reported interactions are indirect Co-IP only","No structural or mutagenesis basis for the proposed signaling mechanisms"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3,7,9,12]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[0,3]}],"localization":[{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[2]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[1,2]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,4,6]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,5]}],"complexes":[],"partners":["KLK5","KLK7","KLK14","FURIN","DSG1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NQ38","full_name":"Serine protease inhibitor Kazal-type 5","aliases":["Lympho-epithelial Kazal-type-related inhibitor","LEKTI"],"length_aa":1064,"mass_kda":120.7,"function":"Serine protease inhibitor, probably important for the anti-inflammatory and/or antimicrobial protection of mucous epithelia. Contribute to the integrity and protective barrier function of the skin by regulating the activity of defense-activating and desquamation-involved proteases. Inhibits KLK5, its major target, in a pH-dependent manner. Inhibits KLK7, KLK14 CASP14, and trypsin","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q9NQ38/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SPINK5","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SPINK5","total_profiled":1310},"omim":[{"mim_id":"615868","title":"SERINE PEPTIDASE INHIBITOR, KAZAL-TYPE, 6; SPINK6","url":"https://www.omim.org/entry/615868"},{"mim_id":"615508","title":"ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE","url":"https://www.omim.org/entry/615508"},{"mim_id":"606797","title":"ST14 TRANSMEMBRANE SERINE PROTEASE MATRIPTASE; ST14","url":"https://www.omim.org/entry/606797"},{"mim_id":"605845","title":"DERMATITIS, ATOPIC, 6; ATOD6","url":"https://www.omim.org/entry/605845"},{"mim_id":"605010","title":"SERINE PROTEASE INHIBITOR, KAZAL-TYPE, 5; SPINK5","url":"https://www.omim.org/entry/605010"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Vesicles","reliability":"Enhanced"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"cervix","ntpm":538.7},{"tissue":"esophagus","ntpm":953.6},{"tissue":"lymphoid tissue","ntpm":274.6},{"tissue":"skin 1","ntpm":300.2},{"tissue":"vagina","ntpm":552.2}],"url":"https://www.proteinatlas.org/search/SPINK5"},"hgnc":{"alias_symbol":["VAKTI","LEKTI","LETKI","NETS","NS","FLJ21544","FLJ97536","FLJ97596","FLJ99794","DKFZp686K19184"],"prev_symbol":[]},"alphafold":{"accession":"Q9NQ38","domains":[{"cath_id":"3.30.60.30","chopping":"23-85","consensus_level":"medium","plddt":76.3868,"start":23,"end":85},{"cath_id":"3.30.60.30","chopping":"283-353","consensus_level":"medium","plddt":80.0031,"start":283,"end":353},{"cath_id":"3.30.60.30","chopping":"365-425","consensus_level":"medium","plddt":74.2392,"start":365,"end":425},{"cath_id":"3.30.60.30","chopping":"434-537","consensus_level":"high","plddt":81.2673,"start":434,"end":537},{"cath_id":"3.30.60.30","chopping":"782-820","consensus_level":"high","plddt":79.2895,"start":782,"end":820},{"cath_id":"3.30.60.30","chopping":"853-905","consensus_level":"medium","plddt":73.7217,"start":853,"end":905},{"cath_id":"3.30.60.30","chopping":"912-965","consensus_level":"high","plddt":78.9656,"start":912,"end":965},{"cath_id":"3.30.60.30","chopping":"995-1044","consensus_level":"high","plddt":87.3598,"start":995,"end":1044}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NQ38","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NQ38-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NQ38-F1-predicted_aligned_error_v6.png","plddt_mean":74.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SPINK5","jax_strain_url":"https://www.jax.org/strain/search?query=SPINK5"},"sequence":{"accession":"Q9NQ38","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NQ38.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NQ38/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NQ38"}},"corpus_meta":[{"pmid":"15106149","id":"PMC_15106149","title":"Insecticide-treated bed nets and curtains for preventing malaria.","date":"2004","source":"The Cochrane database of systematic reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15106149","citation_count":1028,"is_preprint":false},{"pmid":"16218947","id":"PMC_16218947","title":"Flexible nets. The roles of intrinsic disorder in protein interaction networks.","date":"2005","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/16218947","citation_count":935,"is_preprint":false},{"pmid":"24366358","id":"PMC_24366358","title":"Thrombosis: tangled up in NETs.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24366358","citation_count":687,"is_preprint":false},{"pmid":"31736963","id":"PMC_31736963","title":"DAMPs and NETs in Sepsis.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31736963","citation_count":507,"is_preprint":false},{"pmid":"32740860","id":"PMC_32740860","title":"A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics.","date":"2021","source":"Clinical reviews in allergy & immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32740860","citation_count":499,"is_preprint":false},{"pmid":"33042107","id":"PMC_33042107","title":"The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33042107","citation_count":442,"is_preprint":false},{"pmid":"9881847","id":"PMC_9881847","title":"Perineuronal nets: past and present.","date":"1998","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/9881847","citation_count":416,"is_preprint":false},{"pmid":"33431847","id":"PMC_33431847","title":"Perineuronal nets stabilize the grid cell network.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33431847","citation_count":303,"is_preprint":false},{"pmid":"17596512","id":"PMC_17596512","title":"LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17596512","citation_count":237,"is_preprint":false},{"pmid":"32276504","id":"PMC_32276504","title":"Neutrophil Extracellular Traps (NETs) Take the Central Stage in Driving Autoimmune Responses.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32276504","citation_count":225,"is_preprint":false},{"pmid":"34503307","id":"PMC_34503307","title":"Neutrophil Extracellular Traps (NETs) in Cancer Invasion, Evasion and Metastasis.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34503307","citation_count":201,"is_preprint":false},{"pmid":"27446071","id":"PMC_27446071","title":"The Emerging Role of NETs in Venous Thrombosis and Immunothrombosis.","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27446071","citation_count":195,"is_preprint":false},{"pmid":"30398672","id":"PMC_30398672","title":"Insecticide-treated nets for preventing malaria.","date":"2018","source":"The Cochrane database of systematic reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30398672","citation_count":170,"is_preprint":false},{"pmid":"23819131","id":"PMC_23819131","title":"Neutrophil extracellular traps (NETs) - formation and implications.","date":"2013","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/23819131","citation_count":166,"is_preprint":false},{"pmid":"32773102","id":"PMC_32773102","title":"Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression.","date":"2020","source":"Advances in biological regulation","url":"https://pubmed.ncbi.nlm.nih.gov/32773102","citation_count":166,"is_preprint":false},{"pmid":"12915442","id":"PMC_12915442","title":"LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12915442","citation_count":162,"is_preprint":false},{"pmid":"35032828","id":"PMC_35032828","title":"Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.","date":"2022","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35032828","citation_count":157,"is_preprint":false},{"pmid":"25938591","id":"PMC_25938591","title":"Simplified Human Neutrophil Extracellular Traps (NETs) Isolation and Handling.","date":"2015","source":"Journal of visualized experiments : JoVE","url":"https://pubmed.ncbi.nlm.nih.gov/25938591","citation_count":151,"is_preprint":false},{"pmid":"11841556","id":"PMC_11841556","title":"Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families.","date":"2002","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/11841556","citation_count":144,"is_preprint":false},{"pmid":"30629284","id":"PMC_30629284","title":"Untangling \"NETosis\" from NETs.","date":"2019","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30629284","citation_count":140,"is_preprint":false},{"pmid":"12752122","id":"PMC_12752122","title":"Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population.","date":"2003","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/12752122","citation_count":136,"is_preprint":false},{"pmid":"16601670","id":"PMC_16601670","title":"Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome.","date":"2006","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16601670","citation_count":134,"is_preprint":false},{"pmid":"35707534","id":"PMC_35707534","title":"Neutrophil Extracellular Traps (NETs) Promote Non-Small Cell Lung Cancer Metastasis by Suppressing lncRNA MIR503HG to Activate the NF-κB/NLRP3 Inflammasome Pathway.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35707534","citation_count":125,"is_preprint":false},{"pmid":"36902325","id":"PMC_36902325","title":"Molecular Mechanisms of Neutrophil Extracellular Trap (NETs) Degradation.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36902325","citation_count":119,"is_preprint":false},{"pmid":"15675955","id":"PMC_15675955","title":"LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum.","date":"2005","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15675955","citation_count":116,"is_preprint":false},{"pmid":"26927887","id":"PMC_26927887","title":"Social amoebae trap and kill bacteria by casting DNA nets.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26927887","citation_count":104,"is_preprint":false},{"pmid":"31416265","id":"PMC_31416265","title":"Post-Translational Modifications in NETosis and NETs-Mediated Diseases.","date":"2019","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/31416265","citation_count":99,"is_preprint":false},{"pmid":"26839720","id":"PMC_26839720","title":"In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders.","date":"2015","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/26839720","citation_count":99,"is_preprint":false},{"pmid":"29703474","id":"PMC_29703474","title":"Platelets, NETs and cancer.","date":"2018","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/29703474","citation_count":91,"is_preprint":false},{"pmid":"15304086","id":"PMC_15304086","title":"SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases.","date":"2004","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15304086","citation_count":82,"is_preprint":false},{"pmid":"31443560","id":"PMC_31443560","title":"Perineuronal Nets and Their Role in Synaptic Homeostasis.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31443560","citation_count":79,"is_preprint":false},{"pmid":"22730493","id":"PMC_22730493","title":"The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22730493","citation_count":77,"is_preprint":false},{"pmid":"34445556","id":"PMC_34445556","title":"Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34445556","citation_count":77,"is_preprint":false},{"pmid":"16307483","id":"PMC_16307483","title":"Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).","date":"2005","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16307483","citation_count":76,"is_preprint":false},{"pmid":"33466589","id":"PMC_33466589","title":"Significance of NETs Formation in COVID-19.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33466589","citation_count":75,"is_preprint":false},{"pmid":"28428948","id":"PMC_28428948","title":"Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic Fibrosis.","date":"2017","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28428948","citation_count":72,"is_preprint":false},{"pmid":"17989726","id":"PMC_17989726","title":"Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.","date":"2007","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/17989726","citation_count":71,"is_preprint":false},{"pmid":"34885240","id":"PMC_34885240","title":"Neutrophil Extracellular Traps (NETs) in Cancer Metastasis.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/34885240","citation_count":71,"is_preprint":false},{"pmid":"35854322","id":"PMC_35854322","title":"The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren's syndrome.","date":"2022","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/35854322","citation_count":66,"is_preprint":false},{"pmid":"35741047","id":"PMC_35741047","title":"The Fatal Circle of NETs and NET-Associated DAMPs Contributing to Organ Dysfunction.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35741047","citation_count":66,"is_preprint":false},{"pmid":"21697885","id":"PMC_21697885","title":"Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.","date":"2011","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/21697885","citation_count":60,"is_preprint":false},{"pmid":"27614687","id":"PMC_27614687","title":"NETs in cancer.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27614687","citation_count":59,"is_preprint":false},{"pmid":"38189504","id":"PMC_38189504","title":"Neutrophil extracellular traps (NETs) in cardiovascular diseases: From molecular mechanisms to therapeutic interventions.","date":"2023","source":"Kardiologia polska","url":"https://pubmed.ncbi.nlm.nih.gov/38189504","citation_count":58,"is_preprint":false},{"pmid":"20877344","id":"PMC_20877344","title":"Ex-vivo gene therapy restores LEKTI activity and corrects the architecture of Netherton syndrome-derived skin grafts.","date":"2010","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/20877344","citation_count":53,"is_preprint":false},{"pmid":"32845378","id":"PMC_32845378","title":"NETs in APS: Current Knowledge and Future Perspectives.","date":"2020","source":"Current rheumatology reports","url":"https://pubmed.ncbi.nlm.nih.gov/32845378","citation_count":52,"is_preprint":false},{"pmid":"20048772","id":"PMC_20048772","title":"Diverse functions of perineuronal nets.","date":"2009","source":"Acta neurobiologiae experimentalis","url":"https://pubmed.ncbi.nlm.nih.gov/20048772","citation_count":52,"is_preprint":false},{"pmid":"39020018","id":"PMC_39020018","title":"Astrocytes require perineuronal nets to maintain synaptic homeostasis in mice.","date":"2024","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39020018","citation_count":51,"is_preprint":false},{"pmid":"31729003","id":"PMC_31729003","title":"Detection, Visualization, and Quantification of Neutrophil Extracellular Traps (NETs) and NET Markers.","date":"2020","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/31729003","citation_count":51,"is_preprint":false},{"pmid":"23021640","id":"PMC_23021640","title":"Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction.","date":"2012","source":"Blood reviews","url":"https://pubmed.ncbi.nlm.nih.gov/23021640","citation_count":50,"is_preprint":false},{"pmid":"20168283","id":"PMC_20168283","title":"Imaging of NETs with PET radiopharmaceuticals.","date":"2010","source":"The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...","url":"https://pubmed.ncbi.nlm.nih.gov/20168283","citation_count":49,"is_preprint":false},{"pmid":"22017185","id":"PMC_22017185","title":"Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population.","date":"2011","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/22017185","citation_count":47,"is_preprint":false},{"pmid":"35561448","id":"PMC_35561448","title":"Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome.","date":"2022","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/35561448","citation_count":46,"is_preprint":false},{"pmid":"31572386","id":"PMC_31572386","title":"Aggregated NETs Sequester and Detoxify Extracellular Histones.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31572386","citation_count":45,"is_preprint":false},{"pmid":"34194670","id":"PMC_34194670","title":"Staphylococcus aureus induces neutrophil extracellular traps (NETs) and neutralizes their bactericidal potential.","date":"2021","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/34194670","citation_count":45,"is_preprint":false},{"pmid":"29571059","id":"PMC_29571059","title":"Relative antibacterial functions of complement and NETs: NETs trap and complement effectively kills bacteria.","date":"2018","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29571059","citation_count":45,"is_preprint":false},{"pmid":"11943586","id":"PMC_11943586","title":"LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance.","date":"2002","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11943586","citation_count":44,"is_preprint":false},{"pmid":"21585560","id":"PMC_21585560","title":"Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China.","date":"2011","source":"Journal of the European Academy of Dermatology and Venereology : JEADV","url":"https://pubmed.ncbi.nlm.nih.gov/21585560","citation_count":44,"is_preprint":false},{"pmid":"35538389","id":"PMC_35538389","title":"Radiomics in pulmonary neuroendocrine tumours (NETs).","date":"2022","source":"La Radiologia medica","url":"https://pubmed.ncbi.nlm.nih.gov/35538389","citation_count":42,"is_preprint":false},{"pmid":"37287977","id":"PMC_37287977","title":"Targeting NETs using dual-active DNase1 variants.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37287977","citation_count":41,"is_preprint":false},{"pmid":"30868765","id":"PMC_30868765","title":"A novel tumor suppressor SPINK5 targets Wnt/β-catenin signaling pathway in esophageal cancer.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30868765","citation_count":41,"is_preprint":false},{"pmid":"26904301","id":"PMC_26904301","title":"Caught in the Net: Perineuronal Nets and Addiction.","date":"2016","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/26904301","citation_count":41,"is_preprint":false},{"pmid":"37143669","id":"PMC_37143669","title":"Identification of NETs-related biomarkers and molecular clusters in systemic lupus erythematosus.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37143669","citation_count":40,"is_preprint":false},{"pmid":"27923601","id":"PMC_27923601","title":"Understanding the molecular mechanisms of NETs and their role in antiviral innate immunity.","date":"2016","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/27923601","citation_count":40,"is_preprint":false},{"pmid":"15606522","id":"PMC_15606522","title":"LEKTI demonstrable by immunohistochemistry of the skin: a potential diagnostic skin test for Netherton syndrome.","date":"2004","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15606522","citation_count":39,"is_preprint":false},{"pmid":"33577121","id":"PMC_33577121","title":"Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs).","date":"2021","source":"Comprehensive Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33577121","citation_count":38,"is_preprint":false},{"pmid":"33304317","id":"PMC_33304317","title":"mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs).","date":"2020","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/33304317","citation_count":38,"is_preprint":false},{"pmid":"23582918","id":"PMC_23582918","title":"Colonic and rectal NET's.","date":"2012","source":"Best practice & research. Clinical gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23582918","citation_count":38,"is_preprint":false},{"pmid":"27769847","id":"PMC_27769847","title":"Incomplete KLK7 Secretion and Upregulated LEKTI Expression Underlie Hyperkeratotic Stratum Corneum in Atopic Dermatitis.","date":"2016","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/27769847","citation_count":36,"is_preprint":false},{"pmid":"35920993","id":"PMC_35920993","title":"Aging hampers neutrophil extracellular traps (NETs) efficacy.","date":"2022","source":"Aging clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/35920993","citation_count":36,"is_preprint":false},{"pmid":"34484432","id":"PMC_34484432","title":"Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs).","date":"2021","source":"Therapeutic advances in medical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34484432","citation_count":36,"is_preprint":false},{"pmid":"15039071","id":"PMC_15039071","title":"Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.","date":"2004","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/15039071","citation_count":35,"is_preprint":false},{"pmid":"35163333","id":"PMC_35163333","title":"Role of Neutrophils and NETs in Animal Models of Thrombosis.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35163333","citation_count":32,"is_preprint":false},{"pmid":"40102634","id":"PMC_40102634","title":"Neutrophils and NETs in kidney disease.","date":"2025","source":"Nature reviews. Nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/40102634","citation_count":31,"is_preprint":false},{"pmid":"38555028","id":"PMC_38555028","title":"Low-Density Neutrophils and Neutrophil Extracellular Traps (NETs) Are New Inflammatory Players in Heart Failure.","date":"2024","source":"The Canadian journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/38555028","citation_count":31,"is_preprint":false},{"pmid":"36942262","id":"PMC_36942262","title":"The Formation of NETs and Their Mechanism of Promoting Tumor Metastasis.","date":"2023","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36942262","citation_count":31,"is_preprint":false},{"pmid":"16374478","id":"PMC_16374478","title":"SPINK5, the defective gene in netherton syndrome, encodes multiple LEKTI isoforms derived from alternative pre-mRNA processing.","date":"2006","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/16374478","citation_count":31,"is_preprint":false},{"pmid":"25430657","id":"PMC_25430657","title":"GEP-NETs update: Biotherapy for neuroendocrine tumours.","date":"2015","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25430657","citation_count":31,"is_preprint":false},{"pmid":"39384116","id":"PMC_39384116","title":"S100A7 orchestrates neutrophil chemotaxis and drives neutrophil extracellular traps (NETs) formation to facilitate lymph node metastasis in cervical cancer patients.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/39384116","citation_count":30,"is_preprint":false},{"pmid":"38490994","id":"PMC_38490994","title":"TGF-β-driven LIF expression influences neutrophil extracellular traps (NETs) and contributes to peritoneal metastasis in gastric cancer.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38490994","citation_count":30,"is_preprint":false},{"pmid":"37781373","id":"PMC_37781373","title":"The involvement of NETs in ANCA-associated vasculitis.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37781373","citation_count":30,"is_preprint":false},{"pmid":"24825365","id":"PMC_24825365","title":"Differentially instructive extracellular protein micro-nets.","date":"2014","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/24825365","citation_count":29,"is_preprint":false},{"pmid":"24390486","id":"PMC_24390486","title":"Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges.","date":"2014","source":"Cancer metastasis reviews","url":"https://pubmed.ncbi.nlm.nih.gov/24390486","citation_count":28,"is_preprint":false},{"pmid":"33192123","id":"PMC_33192123","title":"Compound K improves skin barrier function by increasing SPINK5 expression.","date":"2019","source":"Journal of ginseng research","url":"https://pubmed.ncbi.nlm.nih.gov/33192123","citation_count":27,"is_preprint":false},{"pmid":"38612596","id":"PMC_38612596","title":"The Dual Role of Neutrophil Extracellular Traps (NETs) in Sepsis and Ischemia-Reperfusion Injury: Comparative Analysis across Murine Models.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38612596","citation_count":26,"is_preprint":false},{"pmid":"11891144","id":"PMC_11891144","title":"The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role.","date":"2002","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/11891144","citation_count":26,"is_preprint":false},{"pmid":"22524286","id":"PMC_22524286","title":"Knotting the NETs: analyzing histone modifications in neutrophil extracellular traps.","date":"2012","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22524286","citation_count":26,"is_preprint":false},{"pmid":"35441845","id":"PMC_35441845","title":"Nets, pulmonary arterial hypertension, and thrombo-inflammation.","date":"2022","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/35441845","citation_count":25,"is_preprint":false},{"pmid":"38906006","id":"PMC_38906006","title":"Nets in fibrosis: Bridging innate immunity and tissue remodeling.","date":"2024","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38906006","citation_count":25,"is_preprint":false},{"pmid":"27418145","id":"PMC_27418145","title":"NETs: organ-related epigenetic derangements and potential clinical applications.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27418145","citation_count":25,"is_preprint":false},{"pmid":"35705923","id":"PMC_35705923","title":"Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis.","date":"2022","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/35705923","citation_count":24,"is_preprint":false},{"pmid":"36359815","id":"PMC_36359815","title":"Correlation between Neutrophil Extracellular Traps (NETs) Expression and Primary Graft Dysfunction Following Human Lung Transplantation.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36359815","citation_count":24,"is_preprint":false},{"pmid":"39617790","id":"PMC_39617790","title":"IL33-induced neutrophil extracellular traps (NETs) mediate a positive feedback loop for synovial inflammation and NET amplification in rheumatoid arthritis.","date":"2024","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39617790","citation_count":23,"is_preprint":false},{"pmid":"39094902","id":"PMC_39094902","title":"NETs: Important players in cancer progression and therapeutic resistance.","date":"2024","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/39094902","citation_count":23,"is_preprint":false},{"pmid":"41335221","id":"PMC_41335221","title":"Neutrophil Extracellular Traps (NETs) in health and disease.","date":"2025","source":"Molecular biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/41335221","citation_count":22,"is_preprint":false},{"pmid":"37187738","id":"PMC_37187738","title":"Who and how, DNA sensors in NETs-driven inflammation.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37187738","citation_count":22,"is_preprint":false},{"pmid":"40806591","id":"PMC_40806591","title":"Unraveling NETs in Sepsis: From Cellular Mechanisms to Clinical Relevance.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40806591","citation_count":21,"is_preprint":false},{"pmid":"21251800","id":"PMC_21251800","title":"rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.","date":"2010","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/21251800","citation_count":20,"is_preprint":false},{"pmid":"33950531","id":"PMC_33950531","title":"Sexually dimorphic perineuronal nets in the rodent and primate reproductive circuit.","date":"2021","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33950531","citation_count":20,"is_preprint":false},{"pmid":"36718937","id":"PMC_36718937","title":"High-salt transcription from enzymatically gapped promoters nets higher yields and purity of transcribed RNAs.","date":"2023","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/36718937","citation_count":20,"is_preprint":false},{"pmid":"38783164","id":"PMC_38783164","title":"naRNA-LL37 composite DAMPs define sterile NETs as self-propagating drivers of inflammation.","date":"2024","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/38783164","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48246,"output_tokens":5318,"usd":0.112254,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13619,"output_tokens":4426,"usd":0.089372,"stage2_stop_reason":"end_turn"},"total_usd":0.201626,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"LEKTI is produced as a precursor that is rapidly cleaved by furin at multiple sites, generating a variety of single or multidomain secreted fragments (D1, D5, D6, D8-D11, D9-D15) in keratinocytes and epidermis. All fragments except D1 specifically inhibit KLK5, KLK7, and KLK14. The D8-D11 fragment shows the strongest inhibition of KLK5 via a rapid, tight (near-irreversible) interaction. This KLK5-LEKTI interaction is pH-dependent: at acidic pH, active KLK5 is released from the complex, providing a mechanism by which the epidermal pH gradient regulates KLK5 activity and corneodesmosomal cleavage in the stratum corneum.\",\n      \"method\": \"Furin inhibitor treatment in cultured keratinocytes, biochemical antibody panel mapping of secreted fragments, kinetic analysis of inhibition (Ki, kass, kdis), pH-dependent binding/release assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinetic reconstitution with multiple LEKTI fragments and target proteases, corroborated by furin inhibitor experiments and pH-dependent release assays in a single rigorous study\",\n      \"pmids\": [\"17596512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"LEKTI is expressed as a 145 kDa full-length protein and a 125 kDa isoform in differentiated human primary keratinocytes; both are N-glycosylated and processed post-ER into C-terminal fragments of 42, 65, and 68 kDa that are secreted. Processing is blocked by a furin inhibitor, and in vitro cleavage of the recombinant 145 kDa precursor by furin generates the 65 and 68 kDa C-terminal fragments, establishing furin as the processing protease.\",\n      \"method\": \"Western blot with monoclonal/polyclonal antibodies, furin inhibitor treatment, in vitro furin cleavage of recombinant LEKTI precursor, N-glycosylation analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution (in vitro furin cleavage) combined with cellular pharmacological inhibition and multiple orthogonal detection methods, replicated across multiple fragment types\",\n      \"pmids\": [\"12915442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In normal human epidermis, LEKTI is localized within lamellar granules (LGs) but is spatially separated from KLK7 and KLK5 within that compartment. LEKTI is expressed and secreted into extracellular spaces of the superficial stratum granulosum earlier than KLK7 and KLK5, suggesting the LG system uses differential timing of secretion to prevent premature degradation of stratum corneum by sequestering the inhibitor from its targets until the appropriate epidermal layer is reached.\",\n      \"method\": \"Confocal laser scanning microscopy and immunoelectron microscopy with co-localization analysis in normal vs. Netherton syndrome skin\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localization by immunoelectron microscopy with functional inference from NS patient comparison; two orthogonal imaging methods in one study\",\n      \"pmids\": [\"15675955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Recombinant LEKTI fragments containing domains 6-8 and 9-12 are potent inhibitors of kallikrein KLK5 (a trypsin-like protease) with Ki of 1.2–5.5 nM at pH 8.0 and 10–20 nM at pH 5.0; dissociation half-life is 20–25 min indicating tight, specific binding. Only fragment 6-9' (not 9-12) inhibits KLK7 (a chymotrypsin-like protease) with Ki of 11 nM at pH 8.0 in a rapidly reversible manner, establishing differential domain selectivity for KLK5 vs KLK7.\",\n      \"method\": \"In vitro enzyme inhibition kinetics with recombinant LEKTI fragments and recombinant KLK5/KLK7; measurement of Ki, kass, kdis at pH 8.0 and pH 5.0\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — rigorous in vitro kinetic reconstitution with recombinant proteins, multiple pH conditions, and differential fragment comparisons\",\n      \"pmids\": [\"16307483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In Netherton syndrome patient skin, the magnitude of serine protease activation correlates with barrier defect severity and inversely with residual LEKTI expression. LEKTI co-localizes with KLK5 and KLK7 in the stratum corneum and inhibits both. Excess serine protease activity causes loss of corneodesmosomes via KLK-mediated degradation of desmoglein 1 (DSG1) and desmocollin 1 (DSC1), while compensatory upregulation of DSG3/DSC3 maintains nucleated epidermal integrity.\",\n      \"method\": \"Serine protease activity assays, LEKTI immunostaining, in situ zymography, western blot for desmosomal proteins in NS patient biopsies stratified by phenotype severity\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal assays in human patient tissue; single study but with defined phenotypic stratification and mechanistic readouts\",\n      \"pmids\": [\"16601670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"LEKTI is synthesized from three distinct high-molecular-weight precursors that undergo a defined proteolytic cascade in the epidermis. Antibody mapping, N-terminal sequencing, and site-specific mutagenesis defined the amino acid sequences of the physiologically generated LEKTI polypeptides and three novel processing intermediates. The most effective fragments against desquamation-related kallikreins (KLK5, KLK7) were identified; LEKTI polypeptides inhibit KLK-mediated proteolysis of desmoglein-1, and quantification shows ratios of LEKTI polypeptides to active KLK5 in the uppermost epidermis are compatible with fine-tuned inhibition.\",\n      \"method\": \"Antibody mapping, N-terminal sequencing, site-specific mutagenesis, in vitro inhibition assays, quantitative western blot of epidermal extracts\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — N-terminal sequencing plus mutagenesis plus functional inhibition assays in a single study; multiple orthogonal methods establishing the proteolytic cascade\",\n      \"pmids\": [\"21697885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The common SPINK5 variant E420K (Glu420Lys) increases the likelihood of furin-dependent cleavage of the LEKTI precursor within the D6-D7 linker region, reversing the cleavage priority for LEKTI activation and preventing formation of the D6D9 fragment, which has the strongest inhibitory activity against KLK5-mediated desmoglein-1 (DSG1) degradation. In 420KK epidermis, KLK5, KLK7, and elastase-2 activities are enhanced, DSG1 expression is reduced, and profilaggrin proteolysis is accelerated. Additionally, 420KK epidermis shows increased expression of the proallergic cytokine TSLP.\",\n      \"method\": \"In vitro furin cleavage assays, in situ and gel zymographies for protease activity, immunohistochemistry, western blot for DSG1 and profilaggrin, TSLP immunostaining in patient epidermis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biochemical reconstitution of altered furin cleavage combined with functional protease activity assays and downstream substrate analysis, multiple orthogonal methods in one study\",\n      \"pmids\": [\"22730493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Recombinant LEKTI domains 6-9' inhibit trypsin (Ki = 356 nM) and subtilisin A (Ki = 193 nM) by a noncompetitive mechanism, whereas recombinant LEKTI domain 6 alone does not inhibit subtilisin A but competitively inhibits trypsin (Ki = 200 nM). Full-length LEKTI inhibits plasmin, cathepsin G, and elastase but domains 6-9' do not, demonstrating domain-specific inhibitory activity.\",\n      \"method\": \"Baculovirus expression and purification of recombinant LEKTI fragments; enzyme inhibition kinetics determining Ki and inhibition mechanism\",\n      \"journal\": \"Protein expression and purification\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified recombinant protein and defined kinetic assays; single lab but rigorous mechanistic characterization\",\n      \"pmids\": [\"15039071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SPINK5 generates three classes of alternatively spliced transcripts encoding three LEKTI isoforms: a 15-domain isoform, a 13-domain isoform, and a longer isoform with a 30-amino acid insertion between domains 13 and 14. In differentiated human keratinocytes, all three LEKTI isoforms are translated into protein, and each precursor generates distinct secreted C-terminal proteolytic fragments from similar cleavage sites, providing an additional mechanism for diversifying bioactive LEKTI fragments.\",\n      \"method\": \"RT-PCR characterization of alternative transcripts, western blot detection of isoform proteins in differentiated keratinocytes, identification of secreted C-terminal fragments\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — alternative splicing verified by RT-PCR and protein confirmed by western blot; functional implication inferred from secreted fragment analysis\",\n      \"pmids\": [\"16374478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"LEKTI is a 15-domain Kazal-type serine proteinase inhibitor isolated from human blood filtrate. Two of the 15 domains closely match the classical Kazal-type pattern (with 6 Cys), while 13 domains have only 4 Cys. Three recombinant LEKTI domains were shown to have significant trypsin-inhibiting activity.\",\n      \"method\": \"Protein isolation from blood filtrate, cDNA cloning, domain structure analysis, in vitro trypsin inhibition assay with recombinant domains\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro inhibition assay with recombinant domains; initial characterization in a single study, foundational but limited in scope\",\n      \"pmids\": [\"11943586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Lentiviral gene transfer of SPINK5 into Netherton syndrome keratinocytes restores LEKTI expression and corrects epidermal architecture in organotypic cultures and in vivo mouse/human skin grafts. Even partial restoration of LEKTI expression in limited cell numbers confers a broader bystander benefit, consistent with LEKTI acting as a secreted inhibitor that can diffuse to neighboring cells.\",\n      \"method\": \"HIV-1-based lentiviral vector transduction of NS keratinocytes, organotypic culture, mouse/human skin engraftment model, immunofluorescence for LEKTI expression and epidermal architecture\",\n      \"journal\": \"Molecular therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo reconstitution models with functional correction readout; single lab study using two model systems\",\n      \"pmids\": [\"20877344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AAV2-mediated gene transfer of full-length SPINK5 cDNA into LEKTI-deficient NS keratinocytes produces a five-fold increase in SPINK5 mRNA reaching ~75% of normal, and restored LEKTI protein demonstrates serine protease inhibitory activity in a hydrolytic activity assay at levels approaching those of healthy keratinocytes.\",\n      \"method\": \"rAAV2 transduction, RT-PCR for mRNA quantification, hydrolytic activity assay for LEKTI function in transduced vs. normal keratinocytes\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — functional rescue assay in patient-derived cells; single lab, single method for activity measurement\",\n      \"pmids\": [\"21251800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Genotype-phenotype correlations in Japanese NS patients show that LEKTI truncation length correlates with cutaneous severity, growth retardation, and skin infection. Using recombinant LEKTI proteins of varying domain length, trypsin-like (Phe-Ser-Arg-) protease activity in stratum corneum is predominantly inhibited by LEKTI domains 6-12, plasmin- and trypsin-like (Pro-Phe-Arg-) activities by domains 12-15, and chymotrypsin-like activity by all domains; furin-like activity is not inhibited by any domain. KLK5 and KLK7 levels are significantly elevated in NS patient stratum corneum and serum.\",\n      \"method\": \"Recombinant LEKTI domain expression and stratum corneum protease activity assays with fluorogenic substrates; KLK ELISA in patient samples; clinical correlation analysis\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro inhibition assays with recombinant domain fragments correlated with patient phenotypes; single lab with multiple domain comparisons\",\n      \"pmids\": [\"17989726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In atopic dermatitis lesional skin, KLK7 secretion from lamellar granules is impaired, and LEKTI expression is upregulated compared to normal skin. KLK activity measured by in situ zymography on tape-stripped corneocytes is not significantly elevated in AD lesions despite increased KLK7 protein, indicating that elevated LEKTI expression constitutes a compensatory mechanism preventing further barrier dysfunction by suppressing KLK activity.\",\n      \"method\": \"Western blot for corneodesmosin degradation patterns, in situ zymography on tape-stripped corneocytes, electron microscopy and immunostaining for KLK7 secretion from lamellar granules, LEKTI immunostaining\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods in patient tissue; single lab study with both protein and activity-level readouts\",\n      \"pmids\": [\"27769847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SPINK5 overexpression in esophageal cancer cells inhibits the Wnt/β-catenin signaling pathway: SPINK5 inhibits GSK3β phosphorylation and promotes β-catenin protein degradation (confirmed with LiCl or MG-132 co-treatment), reducing cell proliferation, migration, and invasion. Co-immunoprecipitation suggested an indirect interaction between SPINK5 and components of this pathway. In vivo, SPINK5 overexpression significantly inhibits esophageal cancer cell growth in a xenograft model.\",\n      \"method\": \"Western blot for Wnt/β-catenin pathway components, LiCl/MG-132 pharmacological rescue experiments, in vivo xenograft model, bioinformatics pathway analysis\",\n      \"journal\": \"Cancer medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — overexpression assay with pathway western blot; indirect interaction not directly demonstrated; single lab, no mutagenesis to map the mechanism\",\n      \"pmids\": [\"30868765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"miR-5100 directly targets SPINK5 (confirmed by luciferase reporter assay), reducing SPINK5 expression and thereby activating STAT3 phosphorylation in melanoma cells. Reduced SPINK5 promotes epithelial-mesenchymal transition and melanoma metastasis. Co-immunoprecipitation confirmed an indirect interaction between SPINK5 and STAT3. Metformin suppresses the miR-5100/SPINK5/STAT3 axis, reducing melanoma cell metastasis to lung in a mouse model.\",\n      \"method\": \"Luciferase reporter assay for miR-5100 targeting SPINK5, western blot for STAT3 phosphorylation, migration/wound healing assays, co-immunoprecipitation for SPINK5-STAT3 interaction, in vivo mouse lung metastasis model\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter validates direct miRNA targeting; Co-IP and in vivo rescue provide mechanistic pathway placement; single lab study\",\n      \"pmids\": [\"35705923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Compound K (an active ginsenoside metabolite) increases SPINK5 gene promoter activity and SPINK5/LEKTI protein expression in UVB-irradiated HaCaT keratinocytes, resulting in decreased downstream KLK5, KLK7, and PAR2 expression. In UVB-irradiated mouse and DNCB-induced atopic dermatitis mouse models, CK treatment restores SPINK5 expression and normalizes the expression of desquamation-related proteins.\",\n      \"method\": \"Transactivation (promoter activity) assay, RT-PCR, western blot, mouse models with TEWL and histology readouts\",\n      \"journal\": \"Journal of ginseng research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological upregulation of SPINK5 with downstream protease readouts; single lab, no direct mechanistic dissection of SPINK5 function itself\",\n      \"pmids\": [\"33192123\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SPINK5 encodes LEKTI, a secreted multi-domain Kazal-type serine protease inhibitor that is synthesized as a high-molecular-weight precursor (from three alternative splice isoforms), processed intracellularly by furin at multiple sites into bioactive fragments, and secreted from lamellar granules into the extracellular spaces of the stratum granulosum, where its fragments differentially and potently inhibit epidermal kallikreins KLK5, KLK7, and KLK14 in a pH-dependent manner to regulate desquamation, corneodesmosome integrity, and skin barrier homeostasis; loss-of-function mutations in SPINK5 cause Netherton syndrome through unchecked kallikrein activity and proteolysis of desmoglein-1 and other structural proteins, while a common E420K variant alters furin cleavage priorities to reduce the most potent inhibitory fragment and predispose to atopic dermatitis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SPINK5 encodes LEKTI, a multi-domain Kazal-type serine protease inhibitor that governs epidermal desquamation and skin barrier homeostasis by restraining kallikrein-mediated proteolysis [#0, #9]. LEKTI is synthesized as high-molecular-weight precursors from three alternatively spliced transcripts (15-domain, 13-domain, and a 30-amino-acid-insertion isoform) and is rapidly cleaved by furin at multiple sites into single- and multi-domain secreted fragments [#1, #8]. These fragments display domain-selective, pH-dependent inhibition of the epidermal kallikreins KLK5, KLK7, and KLK14: multidomain fragments such as D8-D11 and domains 6-12 bind the trypsin-like KLK5 with near-irreversible, nanomolar affinity that is released under the acidic pH of the stratum corneum, while only the domain 6-9' fragment inhibits the chymotrypsin-like KLK7, providing a pH- and layer-dependent switch for protease activity [#0, #3, #12]. Spatially, LEKTI is stored in lamellar granules and secreted into the stratum granulosum ahead of and physically separated from its target kallikreins, ensuring inhibition is engaged only at the appropriate epidermal layer [#2]. By limiting kallikrein activity, LEKTI protects corneodesmosomal proteins desmoglein-1 and desmocollin-1 from degradation; loss-of-function SPINK5 mutations cause Netherton syndrome, in which unchecked serine protease activity degrades these structural proteins and the magnitude of activation scales with barrier-defect severity [#4, #6]. Reintroduction of SPINK5 into patient keratinocytes restores LEKTI expression, protease inhibition, and epidermal architecture, confirming the gene's causal role [#10, #11]. A common E420K variant redirects furin cleavage to prevent formation of the most potent anti-KLK5 fragment, enhancing kallikrein and elastase activity, accelerating desmoglein-1 and profilaggrin proteolysis, and inducing the proallergic cytokine TSLP [#6]. Beyond the epidermis, SPINK5 has been reported to act as a tumor suppressor that restrains Wnt/\\u03b2-catenin signaling in esophageal cancer and STAT3 signaling in melanoma [#14, #15].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established LEKTI as a 15-domain Kazal-type serine protease inhibitor with intrinsic protease-inhibitory activity, defining the molecular class of the protein.\",\n      \"evidence\": \"Protein isolation from blood filtrate, cDNA cloning, and in vitro trypsin inhibition with recombinant domains\",\n      \"pmids\": [\"11943586\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Physiological target proteases not identified\", \"No connection to epidermal biology yet established\", \"Most of the 15 domains untested for activity\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identified furin as the processing protease that converts the LEKTI precursor into secreted C-terminal fragments, defining how the inhibitor is matured.\",\n      \"evidence\": \"Western blot of keratinocyte isoforms, furin inhibitor treatment, and in vitro furin cleavage of recombinant precursor\",\n      \"pmids\": [\"12915442\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Functional differences among fragments not resolved\", \"Target proteases of each fragment not yet defined\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated domain-specific and mechanistically distinct inhibition, showing different LEKTI fragments inhibit different proteases by competitive vs noncompetitive modes.\",\n      \"evidence\": \"Baculovirus-expressed recombinant fragments with kinetic Ki and inhibition-mechanism assays against trypsin, subtilisin, plasmin, cathepsin G, elastase\",\n      \"pmids\": [\"15039071\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Tested proteases are not the principal epidermal kallikreins\", \"Physiological relevance of each target not established\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the differential domain selectivity for the desquamation kallikreins KLK5 vs KLK7 and the pH-dependence of binding, linking LEKTI to epidermal protease regulation.\",\n      \"evidence\": \"In vitro inhibition kinetics with recombinant LEKTI fragments and KLK5/KLK7 at pH 5.0 and 8.0, plus subcellular localization by confocal and immunoelectron microscopy\",\n      \"pmids\": [\"16307483\", \"15675955\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"KLK14 not yet included\", \"In vivo timing of secretion inferred, not directly measured\", \"Substrate consequences of unchecked kallikreins not yet shown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected LEKTI loss to corneodesmosome destruction in Netherton syndrome, identifying DSG1/DSC1 as the kallikrein substrates whose degradation drives the barrier defect.\",\n      \"evidence\": \"Serine protease activity assays, in situ zymography, and desmosomal protein western blots in phenotype-stratified NS patient biopsies\",\n      \"pmids\": [\"16601670\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Causality from patient correlation only\", \"Compensatory DSG3/DSC3 mechanism not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed alternative splicing yields three LEKTI isoforms each generating distinct secreted fragments, expanding the diversity of bioactive inhibitors.\",\n      \"evidence\": \"RT-PCR transcript characterization and western blot of isoform proteins and secreted fragments in differentiated keratinocytes\",\n      \"pmids\": [\"16374478\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Functional differences between isoform-derived fragments not quantified\", \"Tissue-specific isoform regulation unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved the mechanism by which the epidermal pH gradient regulates kallikrein activity, showing acidic pH releases active KLK5 from the most potent D8-D11 fragment.\",\n      \"evidence\": \"Furin inhibitor treatment, antibody fragment mapping, and pH-dependent binding/release kinetics in keratinocytes\",\n      \"pmids\": [\"17596512\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"KLK14 regulation less characterized\", \"In vivo pH-dependent release in stratum corneum inferred from in vitro kinetics\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Mapped genotype-phenotype correlations and domain-resolved protease specificity, linking LEKTI truncation length to clinical severity.\",\n      \"evidence\": \"Recombinant domain fragments tested against stratum corneum protease activities, KLK ELISA in patient samples, and clinical correlation in Japanese NS patients\",\n      \"pmids\": [\"17989726\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Correlative, not causal, link between domain length and phenotype\", \"Single population cohort\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Provided causal proof that restoring SPINK5/LEKTI corrects the Netherton phenotype, validating the gene as the disease driver and therapeutic target.\",\n      \"evidence\": \"Lentiviral and AAV2 gene transfer into NS keratinocytes with organotypic culture, skin grafting, and hydrolytic protease-inhibition assays\",\n      \"pmids\": [\"20877344\", \"21251800\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single-lab model systems\", \"Durability and safety of correction in vivo not addressed\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the precise proteolytic cascade and quantified LEKTI-to-KLK5 ratios in vivo, establishing that fragment generation supports fine-tuned inhibition.\",\n      \"evidence\": \"Antibody mapping, N-terminal sequencing, site-specific mutagenesis, and quantitative western blot of epidermal extracts\",\n      \"pmids\": [\"21697885\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Regulation of cascade ordering not fully resolved\", \"In vivo spatial dynamics of intermediates not visualized\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mechanistically explained the atopic-dermatitis-associated E420K variant, showing it reroutes furin cleavage to abolish the most potent anti-KLK5 fragment and amplify proteolysis and TSLP induction.\",\n      \"evidence\": \"In vitro furin cleavage assays, in situ and gel zymography, DSG1/profilaggrin western blots, and TSLP immunostaining in 420KK epidermis\",\n      \"pmids\": [\"22730493\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Population-level penetrance of variant not addressed\", \"Link from TSLP induction to clinical atopy not directly tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed LEKTI upregulation acts as a compensatory brake in atopic dermatitis, where impaired KLK7 secretion and elevated LEKTI keep net protease activity in check.\",\n      \"evidence\": \"In situ zymography on tape-stripped corneocytes, electron microscopy of lamellar granule secretion, and LEKTI immunostaining in AD lesional skin\",\n      \"pmids\": [\"27769847\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Trigger for compensatory LEKTI upregulation unknown\", \"Single-lab patient cohort\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended SPINK5 function beyond the epidermis, placing it as a target of miR-5100 that restrains STAT3 signaling and melanoma metastasis.\",\n      \"evidence\": \"Luciferase reporter for miR-5100 targeting, STAT3 phosphorylation western blots, Co-IP, and in vivo lung metastasis model with metformin\",\n      \"pmids\": [\"35705923\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"SPINK5-STAT3 interaction described as indirect, not mapped\", \"Mechanism linking a secreted protease inhibitor to intracellular STAT3 unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a secreted Kazal-type protease inhibitor mechanistically engages intracellular signaling cascades (Wnt/\\u03b2-catenin, STAT3) to act as a tumor suppressor remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No direct molecular link between LEKTI and intracellular signaling components\", \"Reported interactions are indirect Co-IP only\", \"No structural or mutagenesis basis for the proposed signaling mechanisms\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 7, 9, 12]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 4, 6]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"KLK5\", \"KLK7\", \"KLK14\", \"FURIN\", \"DSG1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}